Literature DB >> 23636869

Conduction recovery in patients with recurrent atrial fibrillation after pulmonary vein isolation using multi-electrode duty cycled radiofrequency ablation.

J C Balt1, S Karadavut, A A W Mulder, J G L M Luermans, M C E F Wijffels, L V A Boersma.   

Abstract

INTRODUCTION: The pulmonary vein ablation catheter (PVAC) is designed for pulmonary vein isolation (PVI). Electrical reconnection of pulmonary veins is believed to result in AF recurrence. The purpose of this study was to establish the location and extent of PV reconnection after PVI with the PVAC catheter. METHODS AND
RESULTS: Eighty-two patients (79 % male, age 60 ± 9 years) that underwent a redo procedure for recurrent AF after PVAC ablation were assessed for prevalence and location of reconnection. The number of reconnected PV's was 0, 1, 2, 3, or 4 in 2 (2.4 %), 14 (17 %), 23 (28 %), 28 (34 %), and 15 (18 %) patients, respectively. Reconnection of left superior, left inferior, left common, right superior, and right inferior PV's was found in 66, 63, 83, 57, and 67 %, respectively (p = 0.48). In the left PV's, reconnection was located significantly more anterior than posterior; LSPV anterior 32/70 vs posterior 13/70 (p < 0.01), LIPV anterior 26/70 vs posterior 9/70 (p < 0.01). In the right PV's reconnection was distributed equally in all quadrants. Different modes of RF delivery during PVAC ablation (bipolar/unipolar 2:1 [n = 35] vs. 4:1 [n = 47]) yielded comparable rates of PV reconnection. During follow-up (median 296 days) no AF/AT was documented in 57 patients (70 %).
CONCLUSION: Almost all patients (98 %) with AF after PVAC ablation show reconnection of at least one PV. All PV's are equally likely to show reconnection. In the left PV's, reconnection was found more often anteriorly than posteriorly. During pulmonary vein isolation with the PVAC catheter, prevalent sites of reconnection deserve close attention to increase success.

Entities:  

Mesh:

Year:  2013        PMID: 23636869     DOI: 10.1007/s10840-013-9787-5

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  26 in total

1.  2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; Jose Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  Europace       Date:  2012-03-01       Impact factor: 5.214

2.  Morphological evidence of muscular connections between contiguous pulmonary venous orifices: relevance of the interpulmonary isthmus for catheter ablation in atrial fibrillation.

Authors:  José Angel Cabrera; Siew Yen Ho; Vicente Climent; Beatriz Fuertes; Margarita Murillo; Damián Sánchez-Quintana
Journal:  Heart Rhythm       Date:  2009-04-15       Impact factor: 6.343

3.  Freedom from paroxysmal atrial fibrillation after successful pulmonary vein isolation with pulmonary vein ablation catheter-phased radiofrequency energy: 2-year follow-up and predictors of failure.

Authors:  Anton A W Mulder; Maurits C E F Wijffels; Eric F D Wever; Lucas V A Boersma
Journal:  Europace       Date:  2012-02-15       Impact factor: 5.214

4.  Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

Authors:  Riccardo Cappato; Hugh Calkins; Shih-Ann Chen; Wyn Davies; Yoshito Iesaka; Jonathan Kalman; You-Ho Kim; George Klein; Andrea Natale; Douglas Packer; Allan Skanes; Federico Ambrogi; Elia Biganzoli
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-12-07

5.  Pulmonary vein anatomy and long-term outcome after multi-electrode pulmonary vein isolation with phased radiofrequency energy for paroxysmal atrial fibrillation.

Authors:  Anton A W Mulder; Maurits C E F Wijffels; Eric F D Wever; Lucas V A Boersma
Journal:  Europace       Date:  2011-07-22       Impact factor: 5.214

6.  The permanency of pulmonary vein isolation using a balloon cryoablation catheter.

Authors:  Humera Ahmed; Petr Neuzil; Jan Skoda; Andre D'Avila; David M Donaldson; Margaret C Laragy; Vivek Y Reddy
Journal:  J Cardiovasc Electrophysiol       Date:  2010-02-01

7.  Response of atrial fibrillation to pulmonary vein antrum isolation is directly related to resumption and delay of pulmonary vein conduction.

Authors:  Atul Verma; Fethi Kilicaslan; Ennio Pisano; Nassir F Marrouche; Raffaele Fanelli; Johannes Brachmann; Jens Geunther; Domenico Potenza; David O Martin; Jennifer Cummings; J David Burkhardt; Walid Saliba; Robert A Schweikert; Andrea Natale
Journal:  Circulation       Date:  2005-08-02       Impact factor: 29.690

8.  Characterization of in vitro and in vivo lesions made by a novel multichannel ablation generator and a circumlinear decapolar ablation catheter.

Authors:  Maurits C E F Wijffels; Matthijs Van Oosterhout; Lucas V A Boersma; Randy Werneth; Chris Kunis; Betty Hu; Jet D M Beekman; Marc A Vos
Journal:  J Cardiovasc Electrophysiol       Date:  2009-06-01

9.  Incidence and location of focal atrial fibrillation triggers in patients undergoing repeat pulmonary vein isolation: implications for ablation strategies.

Authors:  Edward P Gerstenfeld; David J Callans; Sanjay Dixit; Erica Zado; Francis E Marchlinski
Journal:  J Cardiovasc Electrophysiol       Date:  2003-07

10.  Efficacy of pulmonary vein isolation by cryoballoon ablation in patients with paroxysmal atrial fibrillation.

Authors:  Gunnar Klein; Hanno Oswald; Ajmal Gardiwal; Ulrich Lüsebrink; Christoph Lissel; Hong Yu; Helmut Drexler
Journal:  Heart Rhythm       Date:  2008-02-16       Impact factor: 6.343

View more
  7 in total

Review 1.  Comparison of the Efficacy of PVAC® and nMARQ for paroxysmal atrial fibrillation.

Authors:  Avishag Laish-Farkash; Mahmoud Suleiman
Journal:  J Atr Fibrillation       Date:  2017-04-30

Review 2.  Durable Pulmonary Vein Isolation: The Holy Grail of Atrial Fibrillation Ablation.

Authors:  Duy Thai Nguyen; William H Sauer
Journal:  J Atr Fibrillation       Date:  2013-10-31

3.  Is the time of atrial fibrillation recurrence after cryoballoon ablation of paroxysmal atrial fibrillation influenced by the pattern of PV reconnections?

Authors:  Marcus Wieczorek; Kiarash Sassani; Reinhard Hoeltgen
Journal:  J Interv Card Electrophysiol       Date:  2020-07-03       Impact factor: 1.900

4.  Comparison of pulmonary vein reconnection patterns after multielectrode phased radiofrequency- and cryoballoon ablation of atrial fibrillation.

Authors:  Marcus Wieczorek; Kiarash Sassani; Reinhard Hoeltgen
Journal:  BMC Cardiovasc Disord       Date:  2020-04-23       Impact factor: 2.298

5.  Is the Time of Atrial Fibrillation Recurrence After Duty-Cycled Radiofrequency Ablation Affected by the Pattern of Pulmonary Vein Reconnections?

Authors:  Marcus Wieczorek; Kiarash Sassani; Reinhard Hoeltgen
Journal:  Cardiol Res       Date:  2020-05-03

6.  Correlation of pulmonary vein reconnection patterns after cryoballoon and duty-cycled ablation of atrial fibrillation with the time of arrhythmia recurrence.

Authors:  Marcus Wieczorek; Kiarash Sassani; Reinhard Hoeltgen
Journal:  J Arrhythm       Date:  2020-09-24

7.  Spatial distribution of electrical reconnection after pulmonary vein isolation in patients with recurrent paroxysmal atrial fibrillation.

Authors:  L M Rademakers; I Romero; T A Simmers; P H van der Voort; A M Meijer; L R Dekker
Journal:  Neth Heart J       Date:  2016-07       Impact factor: 2.380

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.